Semaglutide may lower burden of hospitalizations in high-risk patients

For patients at high cardiovascular risk with overweight or obesity, semaglutide is associated with reduced burden of total hospital admissions, according to a study published online in JAMA Cardiology.

Continue Reading

News Source: medicalxpress.com